Additionally, despite the near-ubiquitous expression of APP in the brain, neurodegeneration in AD animal models and human patients seems to be more restricted to specific brain regions in the hippocampus and the cortex, and the molecular basis for this selective vulnerability remains unknown [98]. This evidence concerns the gene APP and Alzheimer disease.